Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Reappraisal of Probiotics’ Safety in Human Publisher Pubmed



Sotoudegan F1 ; Daniali M2, 3 ; Hassani S2, 3 ; Nikfar S4, 5 ; Abdollahi M2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Quality Control of Medicines and Supplements Group, Pharmaceutical Quality Assurance Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Toxicology and Diseases Group, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Evidence-Based Evaluation of Cost-Effectiveness and Clinical Outcomes Group, the Pharmaceutical Management and Economics Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran

Source: Food and Chemical Toxicology Published:2019


Abstract

Contrary to the safe usage of probiotics for years, their threat is still worthy of attention. Several risks have been explained or mentioned in the case reports, clinical trials and experimental studies. Due to a large number of probiotic products worldwide, the certainty of the safety of such products is a matter of concern. Current review appraises all the available information about a range of adverse effects by probiotics in different populations of consumers and almost all qualified investigations and reports, relevant to the adverse effects of probiotics. Furthermore, the effects of basic or original sources of probiotics were studied. The principally noticed adverse effects of probiotics are systemic infections, gastrointestinal side effects, skin complications, inflammation of endocardium, gene transfer from probiotics to the normal microbial flora, metabolic harmful impacts of probiotics, and immune system stimulation. The most at-risk groups consist of infants, elderly people, patients in hospitalized condition, and those with immunodeficiency due to a genetic or acquired disease. The existing evidence suggests careful evaluation of the risk-benefit ratio of probiotics prior to prescription or recommendation to use. © 2019 Elsevier Ltd
1. Safety of Probiotic Bacteria, Probiotics# Prebiotics# and Synbiotics: Bioactive Foods in Health Promotion (2016)
2. Probiotics for Prophylaxis and Management of Breast Cancer: Preclinical and Clinical Evidence, Probiotic Research in Therapeutics: Volume 1: Applications in Cancers and Immunological Diseases (2020)
3. Antibiotic Resistance Propagation Through Probiotics, Expert Opinion on Drug Metabolism and Toxicology (2020)
7. Probiotics and Prebiotics, Encyclopedia of Food Safety# Second Edition# Volume 1-4 (2023)
8. Obstacles and Challenges in the Use of Probiotics, Journal of Babol University of Medical Sciences (2018)
Experts (# of related papers)
Other Related Docs
15. Treating Viral Diarrhea in Children by Probiotic and Zinc Supplements, Pediatric Gastroenterology# Hepatology and Nutrition (2019)